Interactions between adaptable pathogens, drugs and the human host

临床免疫学和生物医学统计中心（CCIBS）代表了皇家珀斯医院和默多克大学之间的合作，汇集了国际公认的临床免疫学，实验生物学和生物统计学和计算创新的专业知识。这些资源已应用于艾滋病毒和丙型肝炎疾病和治疗的广泛框架内的广泛研究问题。CCIBS已成为国际领先的卓越研究中心，建立了创新方法的声誉，以宿主-病毒相互作用，建立在人类和病毒基因组的群体遗传学研究的悠久传统之上，并愿意谈判复杂的计算和统计挑战，以忠实地反映人口水平的动态生物过程。早期认识到大型和综合的遗传和临床数据库是基因组时代研究成功的基础，这也导致了世界上最全面的艾滋病毒基因测序数据库的建立。CCIBS对几个不同研究领域的贡献，包括了解病毒对宿主免疫反应的适应性，预测药物超敏反应的基因检测的发展，以及抗逆转录病毒药物相关毒性的原因，已发表在着名期刊上，包括Science，Nature，Nature Immunology，The Lancet，Proceedings of National Academy of Sciences，和《美国人类遗传学杂志》，并促成了许多国际合作，这些合作认识到CCIBS能够为全球研究工作带来的独特属性，旨在了解艾滋病毒和丙型肝炎生物学和治疗的基本方面。

The Centre for Clinical Immunology and Biomedical Statistics (CCIBS) represents a collaboration between Royal Perth Hospital and Murdoch University that has brought together internationally recognised expertise in clinical immunology, experimental biology and innovation in biostatistics and computing. These resources have been applied to a broad range of research issues within the broad framework of HIV and hepatitis C disease and treatment. CCIBS has become a leading centre of research excellence internationally, establishing a reputation for innovative approaches to host-viral interactions that are built on a long tradition of research into the population genetics of both human and viral genomes, combined with a willingness to negotiate complex computation and statistical challenges in order to faithfully reflect dynamic biological processes at a population level. An early recognition that large and integrated repositories of genetic and clinical data are fundamental to the research success in the genomic era has also led to the creation of the single most comprehensive repository of HIV genetic sequencing data in the world. The contributions that CCIBS has made to several distinct areas of research, including understanding viral adaptation to host immune responses, the development of genetic testing to predict drug hypersensitivity reactions, and causes of antiretroviral drug-associated toxicities, have been published in prestigious journals including Science, Nature, Nature Immunology, The Lancet, Proceedings of National Academy of Sciences, and The American Journal of Human Genetics, and have also resulted in numerous international collaborations that recognise the unique attributes that CCIBS has been able to bring to the global research effort aimed at understanding fundamental aspects of HIV and hepatitis C biology and treatment.